Raised over time
Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.
Financials disclosed in this offering
FY2022–FY2023 · hover for sourceThe fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Amendments to this offering
4 amendments- Apr 22, 2025
- Deadline Apr 30, 2025 → Jun 30, 2025
“Issuer is updating their financial statements per the most recent fiscal year and extending their campaign end date to June 30th, 2025.”
Form C/A on EDGAR ↗ - Apr 4, 2025
- Feb 12, 2025
- Deadline Feb 13, 2025 → Apr 30, 2025
“The offering deadline is extended to 04/30/2025.”
Form C/A on EDGAR ↗ - Nov 18, 2024
- Deadline Jan 29, 2025 → Feb 13, 2025
- Maximum $124K → $1.2M
“The offering deadline is extended to 02/13/2025. The maximum has increased from $124,000 to $1,235,000. The campaign page includes clearer language, disclaimers on product images and FDA status. Exhibit F adds the Articles of Incorporation and amendments.”
Form C/A on EDGAR ↗
Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.
Deal terms
Perks
Offering details
Links & provenance
0001665160-24-001512
Last synced Aug 18, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.